The Scientist - Home

LONDON—Industrial, government and scientific leaders here are about to launch a new effort to decide how best to spend the U.K.'s research dollars. The tripartite forum—as yet unnamed—is expected to be announced shortly by the government, which hopes to attract a well-known industrialist as its chairman. The idea for such a group came from the government's Advisory Council for Applied Research and Development (ACARD). The Council, a group of senior industrial and government res

Ben Schrader wants to be a high school science teacher in Houston. The 55-year-old chemical engineer plans to reach his goal with the help of a new cooperative program, between the Chevron Corporation and three universities, that addresses both the problem of unemployment in the oil industry and the growing shortage of science teachers throughout the nation's secondary schools. Getting a good education has always been important to Schrader, who expects his youngest child, a high school senior, t

In 1975, the Howard Hughes Medical Institute (HHMI) was remarkable more for its namesake, the legendary, ultra-reclusive billionaire, than for its $3 million research program. But Hughes' death in 1976, and the 1985 sale of the Hughes Aircraft Co. for $5 billion, have made the Institute remark-able to the tune of $200 million in biomedical grants last year alone. That figure is expected to climb to $300 million by 1990, making the Institute the largest private medical research organization in th

LONDON—Strategic research in Britain should be funded by a new route that is independent of the support given to academic science through the University Grants Committee and research councils and the customer-contractor relationship used by government departments for applied research. This view is contained in a new report on civilian R&D from the House of Lords Select Committee on Science and Technology, a body of ten peers with considerable experience in science and engineering. The repo

STOCKHOLM—The return of 65-year-old academician Andrei Sakharov has given rise to many questions. One important question for scientists is: To what extent will the former prodigy and the youngest person to be elected a full member of the prestigious Soviet' Academy of Sciences resume his scientific activities, after seven years of isolation in Gorky? Speculation about how he might apply his scientific energies ranges over a large area. His insights might be very useful to those who have st

WASHINGTON—The release of Andrei Sakharov from internal exile in Gorky could lead to improved relations between Soviet scientists and their colleagues around the world, say several scientists active in the human rights movement. The decision December 16 by Soviet party leader Mikhail Gorbachev to allow Sakharov to return to Moscow and to continue both his scientific and human rights activities is generally viewed as a bold move that deserves applause from scientists everywhere. What is les

ALBUQUERQUE, N.M.—University of New Mexico physicist Charles Bickel admits to being surprised by his encounter last summer with Roger Hagengruber, vice president for exploratory systems at Sandia National Laboratories. "I had suspected we were further apart on SDI," he said. The revelation came as the two physicists participated in the Trinity Conference last June in Santa Fe. Before a public forum and assisted by a mediator, they engaged in a process called "dialoguing." After stating the

To biochemist Nitza Cintron, a member of what she describes as "the NASA family," the Challenger accident brought with it a great sense of loss. As chief of the 75-person Biomedical Laboratories at Johnson Space Center, Cintron believes the accident has had a greater impact on operational responsibilities—supporting shuttle flights—than on basic research. But there are lots of projects that can only be done in space which have been temporarily suspended. Some of Cintron's own researc

WASHINGTON—Employees in the biotechnology industry are enjoying more salary increases, cash incentive programs and educational assistance, yet the annual turnover rate for some positions is as high as 23 percent, according to a recent survey conducted by Radford Associates for the Industrial Biotechnology Association. The Biotechnology Compensation and Benefits Survey collected information from 126 biotechnology companies based primarily in the United States and Canada. Salary increases we

WASHINGTON—American companies can learn a great deal from the Japanese approach to research planning and the contribution it makes to productivity, a group of U.S. research directors have concluded after a visit there last fall. But the two countries stand to gain even more from a full and continuous exchange of information, suggest a second group of American and Japanese officials that is in the midst of an extended discussion on issues of scientific collaboration. "In all of Japanese ind

WASHINGTON—A request from Director Erich Bloch for $270 million in additional funds for the National Science Foundation in fiscal 1988 should get a sympathetic hearing on Capitol Hill, according to congressional committee staff. But whether that will translate into votes is not yet clear. Bloch won administration support for the 17 percent increase, from $1.62 billion to nearly $1.9 billion, by arguing that strengthening the university research base is one of the best ways to keep American

WASHINGTON—Six months after the federal government published its set of proposed regulations governing biotechnology, two lawsuits aimed at overturning those regulations have failed. On December 22 Judge Gerhard A. Gesell of the U.S. District Court for the District of Columbia dismissed a suit filed by environmental activist Jeremy Rifkin that sought to overturn the June 26 announcement on the grounds that it bypassed established federal rulemaking procedures. The same day, Gesell dismisse